Terms: = Germ cell tumor AND PMS1, hPMS1, 5378, ENSG00000064933, PMSL1, HNPCC3, DKFZp781M0253
19 results:
1. Management and Long-term Outcomes of Adults With Medulloblastoma: A Single-Center Experience.
Neth BJ; Raghunathan A; Kizilbash SH; Uhm JH; Breen WG; Johnson DR; Daniels DJ; Sener U; Carabenciov ID; Campian JL; Khatua S; Mahajan A; Ruff MW
Neurology; 2023 Sep; 101(12):e1256-e1271. PubMed ID: 37524533
[TBL] [Abstract] [Full Text] [Related]
2. Early switch from run-in treatment with vemurafenib plus cobimetinib to atezolizumab after 3 months leads to rapid loss of tumour control in patients with advanced BRAFV600-positive melanoma: The ImmunoCobiVem phase 2 randomised trial.
Livingstone E; Gogas H; Kandolf-Sekulovic L; Meier F; Eigentler TK; Ziemer M; Terheyden PAM; Gesierich AH; Herbst RA; Kähler KC; Ziogas DC; Mijuskovic Z; Garzarolli M; Garbe C; Roesch A; Ugurel S; Gutzmer R; Grob JJ; Kiecker F; Utikal J; Windemuth-Kieselbach C; Eckhardt S; Zimmer L; Schadendorf D
Eur J Cancer; 2023 Sep; 190():112941. PubMed ID: 37482012
[TBL] [Abstract] [Full Text] [Related]
3. Uncover DNA damage and repair-related gene signature and risk score model for glioma.
Wu Y; Liu L; Huang D; Li Z; Xu R; Cheng M; Chen L; Wang Q; You C
Ann Med; 2023 Dec; 55(1):2200033. PubMed ID: 37086071
[TBL] [Abstract] [Full Text] [Related]
4. Mismatch repair proteins play a role in ATR activation upon temozolomide treatment in MGMT-methylated glioblastoma.
Ganesa S; Sule A; Sundaram RK; Bindra RS
Sci Rep; 2022 Apr; 12(1):5827. PubMed ID: 35388070
[TBL] [Abstract] [Full Text] [Related]
5. Microsatellite Instability Predicts Response to Anti-PD1 Immunotherapy in Metastatic Melanoma.
Roncati L
Acta Dermatovenerol Croat; 2018 Dec; 26(4):341-343. PubMed ID: 30665488
[TBL] [Abstract] [Full Text] [Related]
6. Lynch Syndrome-Related Clear cell Carcinoma of the Cervix: A Case Report.
Nakamura K; Nakayama K; Minamoto T; Ishibashi T; Ohnishi K; Yamashita H; Ono R; Sasamori H; Razia S; Hossain MM; Kamrunnahar S; Ishikawa M; Ishikawa N; Kyo S
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587389
[TBL] [Abstract] [Full Text] [Related]
7. [Male breast cancer: history, epidemiology, genetic and histopathology].
Leinung S; Horn LC; Backe J
Zentralbl Chir; 2007 Oct; 132(5):379-85. PubMed ID: 17907078
[TBL] [Abstract] [Full Text] [Related]
8. Mismatch repair protein hMSH2 in primary drug resistance in in vitro human malignant gliomas.
Rellecke P; Kuchelmeister K; Schachenmayr W; Schlegel J
J Neurosurg; 2004 Oct; 101(4):653-8. PubMed ID: 15481721
[TBL] [Abstract] [Full Text] [Related]
9. Altered expression and new mutations in DNA mismatch repair genes MLH1 and MSH2 in melanoma brain metastases.
Korabiowska M; König F; Verheggen R; Schlott T; Cordon-Cardo C; Romeike B; Brinck U
Anticancer Res; 2004; 24(2B):981-6. PubMed ID: 15161053
[TBL] [Abstract] [Full Text] [Related]
10. Relationship between DNA mismatch repair genes expression, Ku-genes expression and ploidy-related parameters in the progression of pigmented lesions of the skin.
Korabiowska M; Tscherny M; Stachura J; Ruschenburg I; Cordon-Cardo C; Brinck U
In Vivo; 2002; 16(5):317-21. PubMed ID: 12494870
[TBL] [Abstract] [Full Text] [Related]
11. Defects of DNA mismatch repair in human prostate cancer.
Chen Y; Wang J; Fraig MM; Metcalf J; Turner WR; Bissada NK; Watson DK; Schweinfest CW
Cancer Res; 2001 May; 61(10):4112-21. PubMed ID: 11358834
[TBL] [Abstract] [Full Text] [Related]
12. Analysis of the DNA mismatch repair proteins expression in malignant melanomas.
Korabiowska M; Brinck U; Dengler H; Stachura J; Schauer A; Droese M
Anticancer Res; 2000; 20(6B):4499-505. PubMed ID: 11205295
[TBL] [Abstract] [Full Text] [Related]
13. Comparative study of the expression of DNA mismatch repair genes, the adenomatous polyposis coli gene and growth arrest DNA damage genes in melanoma recurrences and metastases.
Korabiowska M; Brinck U; Kotthaus I; Berger H; Droese M
Melanoma Res; 2000 Dec; 10(6):537-44. PubMed ID: 11198475
[TBL] [Abstract] [Full Text] [Related]
14. Loss of DNA-mismatch repair gene expression in oral melanomas.
Korabiowska M; Brinck U; Ruschenburg I; Honig JF; Stachura J; Droese M
Oncol Rep; 1999; 6(4):921-3. PubMed ID: 10373682
[TBL] [Abstract] [Full Text] [Related]
15. Single dose of octreotide stabilize metastatic gastro-entero-pancreatic endocrine tumours.
Angeletti S; Corleto VD; Schillaci O; Moretti A; Panzuto F; Annibale B; Delle Fave G
Ital J Gastroenterol Hepatol; 1999; 31(1):23-7. PubMed ID: 10091100
[TBL] [Abstract] [Full Text] [Related]
16. Reduced expression of mismatch repair genes measured by multiplex reverse transcription-polymerase chain reaction in human gliomas.
Wei Q; Bondy ML; Mao L; Gaun Y; Cheng L; Cunningham J; Fan Y; Bruner JM; Yung WK; Levin VA; Kyritsis AP
Cancer Res; 1997 May; 57(9):1673-7. PubMed ID: 9135006
[TBL] [Abstract] [Full Text] [Related]
17. DNA mismatch repair in lymphoblastoid cells from hereditary non-polyposis colorectal cancer (HNPCC) patients is normal under conditions of rapid cell division and increased mutational load.
Tomlinson IP; Hampson R; Karran P; Bodmer WF
Mutat Res; 1997 Mar; 383(2):177-82. PubMed ID: 9088350
[TBL] [Abstract] [Full Text] [Related]
18. Increased labeling of human melanoma cells in vitro using combinations of monoclonal antibodies recognizing separate cell surface antigenic determinants.
Krizan Z; Murray JL; Hersh EM; Rosenblum MG; Glenn HJ; Gschwind CR; Carlo DJ
Cancer Res; 1985 Oct; 45(10):4904-9. PubMed ID: 2411391
[TBL] [Abstract] [Full Text] [Related]
19. Ectopic pro-opiolipomelanocortin: sequence of cDNA coding for beta-melanocyte-stimulating hormone and beta-endorphin.
DeBold CR; Schworer ME; Connor TB; Bird RE; Orth DN
Science; 1983 May; 220(4598):721-3. PubMed ID: 6301015
[TBL] [Abstract] [Full Text] [Related]
